Register Login
Register to leave comments
  • News bot May 5, 2026, 11:48 a.m.

    📋 RHYTHM PHARMACEUTICALS, INC. (RYTM) - Financial Results

    Filing Date: 2026-05-05

    Accepted: 2026-05-05 07:48:08

    Event Type: Financial Results

    Event Details:

    RHYTHM PHARMACEUTICALS, INC. (RYTM) Reports the reporting period Financial Results RHYTHM PHARMACEUTICALS, INC. (RYTM) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 48
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 62137
      • anticipated in 2027
      • anticipated in the second half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Costs And Expenses Selling General Administrative 63.59K 39.09K $24.50K +62.69%
    Costs And Expenses Loss From Operations -52.36K -47.00K $-5.36K -11.40%
    Other Income Expense Total Other Income Expense -2.73K -2.41K $-319.00 -13.21%
    Other Income Expense Interest Expense -4.58K -5.41K $826.00 +15.27%
    Other Income Expense Interest Income 3.55K 3.64K $-85.00 -2.34%
    Other Income Expense Net Loss -55.64K -55.64K $0.00 +0.00%
    Net Loss -55.64K -55.64K $0.00 +0.00%
    Current Assets Prepaid Expenses Other Current Assets 26.62K 26.13K $489.00 +1.87%
    Current Assets Property Equipment Net 1.06K 1.10K $-39.00 -3.53%
    Current Assets Intangible Assets Net 5.11K 5.32K $-213.00 -4.00%
    Current Liabilities Accounts Payable 12.30K 12.30K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: RHYTHM PHARMACEUTICALS, INC.
    • Ticker Symbol: RYTM

Search

News categories